The global endometrial ablation market size is expected to reach USD 1.69 billion by 2030, expanding at a CAGR of 5.16% from 2023 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the growing prevalence of gynecological disorders and public awareness about endometrial ablation procedures. According to the Endocrine Society, PCOS affects between 7% and 10% of all women of reproductive age and is the foremost cause of infertility, which will certainly contribute to the overall market growth. Furthermore, the increased emphasis on raising awareness of gynecological cancer and the increasing prevalence of adenomyosis in women, especially after the age of 50 years, will have a positive impact on endometrial ablation surgery worldwide.
As per the United Nations ESCAP, out of the total population, around 53.2% of the population aged 60 years and above were women, and around 61.2% of the population aged 80 years and more were women in 2020. Thus, the rise in the geriatric women population also contributes to the market growth. Despite these favorable growth environments, the potential complications connected with uterine ablation surgery, like uterine perforation, high fever, and shortness of breath, may slightly impede market dynamics. Moreover, it has become possible to destroy the endometrium in situ in a day-care procedure due to the availability of minimally invasive endometrial ablation procedures as an alternative to surgeries. This procedure is less risky and technically simple to perform.
According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby expected to propel the growth of the overall market. The global market players are undertaking various initiatives, such as organizing social media campaigns and launching websites to raise awareness about women-associated diseases, such as the AUB. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in August 2022, Minerva Surgical, Inc. launched a “Time to Talk” social media campaign and local event series. This initiative will help raise awareness about AUB worldwide. This initiative will increase the consumer base for endometrial ablation devices, driving revenue generation.
Request a free sample copy or view report summary: Endometrial Ablation Market Report
In 2022, the radiofrequency ablation (RFA) product segment dominated the market owing to the increased demand for RFA devices for removal of endometrial layers
In 2022, the clinics segment dominated the market owing to the increased preference for clinics over hospitals to perform endometrial ablation procedures
North America held the largest share in 2022 owing to the rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices
Market players adopt various strategies to increase the reach of their products in the market and improve availability in diverse geographic areas
Grand View Research has segmented the global endometrial ablation market on the basis of product, end-use, and region:
Endometrial Ablation Product Outlook (Revenue, USD Million, 2018 - 2030)
Cryoablation
Radiofrequency Ablation
Hydrothermal Ablation
Thermal Balloon
Microwave Energy
Others
Endometrial Ablation End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Endometrial Ablation Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Endometrial Ablation Market
Medtronic
The Cooper Companies, Inc.
Boston Scientific Corporation
Johnson & Johnson Service Inc.
Olympus Corporation
Richard Wolf GmbH
AngioDynamics
Hologic, Inc.
Minerva Surgical, Inc.
"The quality of research they have done for us has been excellent..."